AVTX vs RL · P/E 0.0, rev $441.0K vs P/E 24, rev $8.11B
Avalo Therapeutics Inc (AVTX) versus Ralph Lauren Corp Class A (RL) — a side-by-side from cached financials, not a winner call.
Avalo Therapeutics Inc (AVTX) is a biotechnology company listed on US.
Ralph Lauren Corp Class A (RL) is a apparel manufacturing company listed on US.
Latest reported AVTX revenue for 2024-12-31 was $441.0K. Net income was -$35.1M. Revenue was down 77.1% from 2023-12-31 to 2024-12-31. AVTX currently screens at market cap $51.5M and trailing P/E 0.0.
Latest reported RL revenue for 2026-03-28 was $8.11B. Net income was $941.1M. Revenue was up 14.6% from 2025-03-29 to 2026-03-28. RL currently screens at market cap $16.95B and trailing P/E 24.1.
AVTX currently screens at market cap $51.5M and trailing P/E 0.0. RL currently screens at market cap $16.95B and trailing P/E 24.1.
Not investment advice. Open the AVTX and RL stock pages for the full models.
Not investment advice.